Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback